Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS: CHGCY · Delayed Price · USD
18.56
+0.57 (3.17%)
Jul 3, 2024, 12:26 PM EDT - Market closed
Chugai Pharmaceutical Co. Market Cap
Chugai Pharmaceutical Co. has a market cap or net worth of $61.08 billion as of July 3, 2024. Its market cap has increased by 152.90% in one year.
Market Cap
61.08B
Enterprise Value
56.39B
1-Year Change
152.90%
Ranking
n/a
Category
Stock Price
$18.56
Market Cap Chart
Since July 5, 2019, Chugai Pharmaceutical Co.'s market cap has increased from $37.18B to $61.08B, an increase of 64.26%. That is a compound annual growth rate of 10.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2024 | 30.47B | -1.75% |
| Dec 29, 2023 | 31.01B | 48.80% |
| Dec 30, 2022 | 20.84B | -61.26% |
| Dec 31, 2021 | 53.80B | -38.42% |
| Dec 31, 2020 | 87.37B | 72.16% |
| Dec 31, 2019 | 50.75B | 36.49% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 848.68B |
| Novo Nordisk | 616.52B |
| UnitedHealth Group | 450.80B |
| Johnson & Johnson | 349.23B |
| Merck & Co. | 319.26B |
| AbbVie | 290.26B |
| AstraZeneca | 237.90B |
| Novartis AG | 208.85B |